重大事件
即時報告
8-K
2026-06-05
BioCardia 提交8-K披露非公開信息 投資者需關注附件99.1
AI 繁中摘要
BioCardia, Inc.（納斯達克代碼：BCDA）於2026年6月5日向SEC提交了一份8-K申報文件 📄。該文件主要涉及兩項內容：Item 7.01（監管FD披露）以及Item 9.01（財務報表及附件）。公司根據Regulation FD的規定，主動披露了某些非公開信息，相關詳情已作為附件99.1提交。總部位於加州Sunnyvale的BioCardia專注於生物製劑領域（SIC 2836），此次披露可能與其臨床開發、合作進展或業務更新有關。由於FD披露的具體內容未在摘要中列明，投資者應直接查閱附件99.1全文以了解完整訊息。是次申報不涉及財務業績或重大合約變更，但任何未公開信息的釋放均可能對股價產生短期影響，建議投資者留意相關披露內容 ⚠️。
展開英文正文
EDGAR Filing Documents for 0001437749-26-019653 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001437749-26-019653 Filing Date 2026-06-05 Accepted 2026-06-05 08:00:10 Documents 13 Period of Report 2026-06-05 Items Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 FORM 8-K bcda20260605d_8k.htm iXBRL 8-K 30580 2 EXHIBIT 99.1 ex_972814.htm EX-99.1 12511 Complete submission text file 0001437749-26-019653.txt 177957 Data Files Seq Description Document Type Size 3 XBRL TAXONOMY EXTENSION SCHEMA bcda-20260605.xsd EX-101.SCH 3578 4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20260605_def.xml EX-101.DEF 11423 5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20260605_lab.xml EX-101.LAB 15309 6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20260605_pre.xml EX-101.PRE 11583 16 EXTRACTED XBRL INSTANCE DOCUMENT bcda20260605d_8k_htm.xml XML 2824 Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085 Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123 BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings) EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 261066893 SIC: 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)